{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T15:34:39Z","timestamp":1792510479363,"version":"4.5.0"},"reference-count":77,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007052","name":"Memorial Sloan-Kettering Cancer Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007052","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","redjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.ijrobp.2023.05.032","type":"journal-article","created":{"date-parts":[[2023,5,25]],"date-time":"2023-05-25T12:28:44Z","timestamp":1685017724000},"page":"955-965","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Activation of STING in Response to Partial-Tumor Radiation Exposure"],"prefix":"10.1016","volume":"117","author":[{"given":"Mickael","family":"Mathieu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadna","family":"Budhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prerna R.","family":"Nepali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Russell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon N.","family":"Powell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Humm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph O.","family":"Deasy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana","family":"Haimovitz-Friedman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2023.05.032_bib0001","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1667\/RR3819.1","article-title":"In vivo effects of lattice radiation therapy on local and distant lung cancer: Potential role of immunomodulation","volume":"182","author":"Kanagavelu","year":"2014","journal-title":"Radiat Res"},{"key":"10.1016\/j.ijrobp.2023.05.032_bib0002","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.currproblcancer.2015.10.003","article-title":"The immune mechanisms of abscopal effect in radiation therapy","volume":"40","author":"Grass","year":"2016","journal-title":"Curr Probl Cancer"},{"key":"10.1016\/j.ijrobp.2023.05.032_bib0003","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/nrclinonc.2015.120","article-title":"Opportunities and challenges of radiotherapy for treating cancer","volume":"12","author":"Schaue","year":"2015","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.ijrobp.2023.05.032_bib0004","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.canlet.2013.09.018","article-title":"Abscopal effects of radiation therapy: A clinical review for the radiobiologist","volume":"356","author":"Siva","year":"2015","journal-title":"Cancer Lett"},{"key":"10.1016\/j.ijrobp.2023.05.032_bib0005","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.currproblcancer.2015.10.001","article-title":"Systematic review of case reports on the abscopal effect","volume":"40","author":"Abuodeh","year":"2016","journal-title":"Curr Probl Cancer"},{"key":"10.1016\/j.ijrobp.2023.05.032_bib0006","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3389\/fonc.2014.00325","article-title":"Combinations of immunotherapy and radiation in cancer therapy","volume":"4","author":"Vatner","year":"2014","journal-title":"Front Oncol"},{"key":"10.1016\/j.ijrobp.2023.05.032_bib0007","first-page":"e389","article-title":"The use of lattice radiation therapy (LRT) in the treatment of bulky tumors: A case report of a large metastatic mixed mullerian ovarian tumor","volume":"7","author":"Blanco Suarez","year":"2015","journal-title":"Cureus"},{"key":"10.1016\/j.ijrobp.2023.05.032_bib0008","article-title":"Spatially fractionated stereotactic body radiotherapy (Lattice SBRT) for large tumors","volume":"6","author":"Duriseti","year":"2021","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2023.05.032_bib0009","doi-asserted-by":"crossref","first-page":"e520","DOI":"10.1016\/j.ijrobp.2020.07.1631","article-title":"The use of lattice radiation therapy in patients with voluminous tumors","volume":"108","author":"Amendola","year":"2020","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2023.05.032_bib0010","doi-asserted-by":"crossref","first-page":"129","DOI":"10.2174\/157436207780619509","article-title":"Potential utilization of bystander\/abscopal-mediated signal transduction events in the treatment of solid tumors","volume":"2","author":"Peters","year":"2007","journal-title":"Curr Signal Transduct Ther"},{"key":"10.1016\/j.ijrobp.2023.05.032_bib0011","first-page":"30","article-title":"Spatially fractionated radiation therapy: History, present and the future","volume":"20","author":"Yan","year":"2019","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2023.05.032_bib0012","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1165\/ajrcmb.18.2.2565m","article-title":"Involvement of intercellular adhesion molecule-1 in the antigen-induced infiltration of eosinophils and lymphocytes into the airways in a murine model of pulmonary inflammation","volume":"18","author":"Chin","year":"1998","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.ijrobp.2023.05.032_bib0013","doi-asserted-by":"crossref","first-page":"3401","DOI":"10.4049\/jimmunol.174.6.3401","article-title":"The role of intercellular adhesion molecule-1\/LFA-1 interactions in the generation of tumor-specific CD8+ T cell responses","volume":"174","author":"Jenkinson","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.ijrobp.2023.05.032_bib0014","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.ijrobp.2018.10.009","article-title":"An antitumor immune response is evoked by partial-volume single-dose radiation in 2 murine models","volume":"103","author":"Markovsky","year":"2019","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2023.05.032_bib0015","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1126\/science.1232458","article-title":"Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway","volume":"339","author":"Sun","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.ijrobp.2023.05.032_bib0016","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2019.05.036","article-title":"STING polymer structure reveals mechanisms for activation, hyperactivation, and inhibition","volume":"178","author":"Ergun","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.ijrobp.2023.05.032_bib0017","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/s41586-019-1000-2","article-title":"Structural basis of STING binding with and phosphorylation by TBK1","volume":"567","author":"Zhang","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.ijrobp.2023.05.032_bib0018","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.chom.2015.07.001","article-title":"STING activation by translocation from the ER is associated with infection and autoinflammatory disease","volume":"18","author":"Dobbs","year":"2015","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.ijrobp.2023.05.032_bib0019","doi-asserted-by":"crossref","first-page":"11932","DOI":"10.1038\/ncomms11932","article-title":"Activation of STING requires palmitoylation at the golgi","volume":"7","author":"Mukai","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/j.ijrobp.2023.05.032_bib0020","doi-asserted-by":"crossref","first-page":"ra20","DOI":"10.1126\/scisignal.2002521","article-title":"STING specifies IRF3 phosphorylation by TBK1 in the cytosolic DNA signaling pathway","volume":"5","author":"Tanaka","year":"2012","journal-title":"Sci Signal"},{"key":"10.1016\/j.ijrobp.2023.05.032_bib0021","doi-asserted-by":"crossref","first-page":"aaa2630","DOI":"10.1126\/science.aaa2630","article-title":"Phosphorylation of innate immune adaptor proteins MAVS, STING, and TRIF induces IRF3 activation","volume":"347","author":"Liu","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.ijrobp.2023.05.032_bib0022","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1038\/nri3921","article-title":"STING: Infection, inflammation and cancer","volume":"15","author":"Barber","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.ijrobp.2023.05.032_bib0023","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1126\/science.1229963","article-title":"Cyclic GMP-AMP is an endogenous second messenger in innate immune signaling by cytosolic DNA","volume":"339","author":"Wu","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.ijrobp.2023.05.032_bib0024","first-page":"363","article-title":"cGAS in action: Expanding roles in immunity and inflammation","author":"Ablasser","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.ijrobp.2023.05.032_bib0025","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/nature12640","article-title":"Cell intrinsic immunity spreads to bystander cells via the intercellular transfer of cGAMP","volume":"503","author":"Ablasser","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.ijrobp.2023.05.032_bib0026","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1158\/0008-5472.CAN-10-2820","article-title":"The efficacy of radiotherapy relies upon induction of type I interferon-dependent innate and adaptive immunity","volume":"71","author":"Burnette","year":"2011","journal-title":"Cancer Res"},{"key":"10.1016\/j.ijrobp.2023.05.032_bib0027","doi-asserted-by":"crossref","first-page":"5874","DOI":"10.4049\/jimmunol.1202612","article-title":"Radiation-induced equilibrium is a balance between tumor cell proliferation and T cell-mediated killing","volume":"190","author":"Liang","year":"2013","journal-title":"J Immunol"},{"key":"10.1016\/j.ijrobp.2023.05.032_bib0028","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1146\/annurev-immunol-032713-120156","article-title":"Innate immune sensing and signaling of cytosolic nucleic acids","volume":"32","author":"Wu","year":"2014","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.ijrobp.2023.05.032_bib0029","doi-asserted-by":"crossref","DOI":"10.1016\/j.molcel.2018.07.034","article-title":"Non-canonical activation of the DNA sensing adaptor STING by ATM and IFI16 mediates NF-\u03baB signaling after nuclear DNA damage","volume":"71","author":"Dunphy","year":"2018","journal-title":"Mol Cell"},{"key":"10.1016\/j.ijrobp.2023.05.032_bib0030","first-page":"e4263","article-title":"Safety and efficacy of lattice radiotherapy in voluminous non-small cell lung cancer","volume":"11","author":"Amendola","year":"2019","journal-title":"Cureus"},{"key":"10.1016\/j.ijrobp.2023.05.032_bib0031","first-page":"68","article-title":"Improved outcome of treating locally advanced lung cancer with the use of lattice radiotherapy (LRT): A case report","volume":"9","author":"Amendola","year":"2018","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2023.05.032_bib0032","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.3389\/fimmu.2021.680503","article-title":"Radiation-induced immunity and toxicities: The versatility of the cGAS-STING pathway","volume":"12","author":"Constanzo","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.ijrobp.2023.05.032_bib0033","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2019.09.065","article-title":"Cancer-cell-intrinsic cGAS expression mediates tumor immunogenicity","volume":"29","author":"Schadt","year":"2019","journal-title":"Cell Rep"},{"key":"10.1016\/j.ijrobp.2023.05.032_bib0034","doi-asserted-by":"crossref","DOI":"10.1016\/j.immuni.2018.09.016","article-title":"Tumor-derived cGAMP triggers a STING-mediated interferon response in non-tumor cells to activate the NK cell response","volume":"49","author":"Marcus","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/j.ijrobp.2023.05.032_bib0035","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/nrd2805","article-title":"Averting inflammation by targeting the cytokine environment","volume":"9","author":"Kopf","year":"2010","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.ijrobp.2023.05.032_bib0036","article-title":"Radiotherapy and cytokine storm: Risk and mechanism","volume":"11","author":"Zhang","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.ijrobp.2023.05.032_bib0037","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1189\/jlb.3MA1016-451RR","article-title":"TLR9 expression and secretion of LIF by prostate cancer cells stimulates accumulation and activity of polymorphonuclear MDSCs","volume":"102","author":"Won","year":"2017","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.ijrobp.2023.05.032_bib0038","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.693724","article-title":"Emerging perspectives on leukemia inhibitory factor and its receptor in cancer","volume":"11","author":"Christianson","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.ijrobp.2023.05.032_bib0039","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1186\/s12974-018-1326-y","article-title":"Leukemia inhibitory factor modulates the peripheral immune response in a rat model of emergent large vessel occlusion","volume":"15","author":"Davis","year":"2018","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.ijrobp.2023.05.032_bib0040","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.cytogfr.2011.10.001","article-title":"Understanding the mechanism of IL-1\u03b2 secretion","volume":"22","author":"Lopez-Castejon","year":"2011","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.ijrobp.2023.05.032_bib0041","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s41232-019-0101-5","article-title":"The role of interleukin-1 in general pathology","volume":"39","author":"Kaneko","year":"2019","journal-title":"Inflamm Regen"},{"key":"10.1016\/j.ijrobp.2023.05.032_bib0042","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1073\/pnas.1814642116","article-title":"IL-15 is a component of the inflammatory milieu in the tumor microenvironment promoting antitumor responses","volume":"116","author":"Carrero","year":"2019","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.ijrobp.2023.05.032_bib0043","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.4049\/jimmunol.1101877","article-title":"Targeting TNF-\u03b1 to neoangiogenic vessels enhances lymphocyte infiltration in tumors and increases the therapeutic potential of immunotherapy","volume":"188","author":"Calcinotto","year":"2012","journal-title":"J Immunol"},{"key":"10.1016\/j.ijrobp.2023.05.032_bib0044","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.3389\/fimmu.2019.01818","article-title":"The TNF paradox in cancer progression and immunotherapy","volume":"10","author":"Montfort","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.ijrobp.2023.05.032_bib0045","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1038\/s41598-020-58642-y","article-title":"TNF-\u03b1 increases breast cancer stem-like cells through up-regulating TAZ expression via the non-canonical NF-\u03baB pathway","volume":"10","author":"Liu","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.ijrobp.2023.05.032_bib0046","first-page":"381","article-title":"Managing the adverse effects of radiation therapy","volume":"82","author":"Berkey","year":"2010","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.ijrobp.2023.05.032_bib0047","series-title":"Adverse effects of radiation therapy","author":"Majeed","year":"2023"},{"key":"10.1016\/j.ijrobp.2023.05.032_bib0048","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1038\/s12276-021-00640-9","article-title":"Tumor microenvironment and radioresistance","volume":"53","author":"Suwa","year":"2021","journal-title":"Exp Mol Med"},{"key":"10.1016\/j.ijrobp.2023.05.032_bib0049","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0360-3016(82)90392-3","article-title":"Tumor radioresistance in clinical radiotherapy","volume":"8","author":"Peters","year":"1982","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2023.05.032_bib0050","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.bbadis.2013.11.006","article-title":"Antiviral signaling protein MITA acts as a tumor suppressor in breast cancer by regulating NF-\u03baB induced cell death","volume":"1842","author":"Bhatelia","year":"2014","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.ijrobp.2023.05.032_bib0051","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.celrep.2015.12.029","article-title":"Deregulation of STING signaling in colorectal carcinoma constrains DNA damage responses and correlates with tumorigenesis","volume":"14","author":"Xia","year":"2016","journal-title":"Cell Rep"},{"key":"10.1016\/j.ijrobp.2023.05.032_bib0052","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1158\/0008-5472.CAN-14-3619","article-title":"Radiotherapy combined with novel STING-targeting oligonucleotides results in regression of established tumors","volume":"76","author":"Baird","year":"2016","journal-title":"Cancer Res"},{"key":"10.1016\/j.ijrobp.2023.05.032_bib0053","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s00005-017-0481-7","article-title":"STING signaling in cancer cells: Important or not?","volume":"66","author":"Sokolowska","year":"2018","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"key":"10.1016\/j.ijrobp.2023.05.032_bib0054","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.3389\/fimmu.2017.01933","article-title":"Editorial: Radiation and the immune system: Current knowledge and future perspectives","volume":"8","author":"Lumniczky","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.ijrobp.2023.05.032_bib0055","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1177\/153303460200100207","article-title":"The impact of TNF-alpha induction on therapeutic efficacy following high dose spatially fractionated (GRID) radiation","volume":"1","author":"Sathishkumar","year":"2002","journal-title":"Technol Cancer Res Treat"},{"key":"10.1016\/j.ijrobp.2023.05.032_bib0056","doi-asserted-by":"crossref","DOI":"10.1016\/j.immuni.2019.01.006","article-title":"Clonal deletion of tumor-specific T cells by interferon-\u03b3 confers therapeutic resistance to combination immune checkpoint blockade","volume":"50","author":"Pai","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.ijrobp.2023.05.032_bib0057","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s40364-020-00228-x","article-title":"Roles of IFN-\u03b3 in tumor progression and regression: A review","volume":"8","author":"Jorgovanovic","year":"2020","journal-title":"Biomark Res"},{"key":"10.1016\/j.ijrobp.2023.05.032_bib0058","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1008335","article-title":"STING promotes NLRP3 localization in ER and facilitates NLRP3 deubiquitination to activate the inflammasome upon HSV-1 infection","volume":"16","author":"Wang","year":"2020","journal-title":"PLOS Pathog"},{"key":"10.1016\/j.ijrobp.2023.05.032_bib0059","doi-asserted-by":"crossref","first-page":"492","DOI":"10.4049\/jimmunol.1301812","article-title":"MPYS\/STING-mediated TNF-\u03b1, not type I IFN, is essential for the mucosal adjuvant activity of (3\u2019-5\u2019)-cyclic-di-guanosine-monophosphate in vivo","volume":"192","author":"Blaauboer","year":"2014","journal-title":"J Immunol"},{"key":"10.1016\/j.ijrobp.2023.05.032_bib0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103314","article-title":"A STING antagonist modulating the interaction with STIM1 blocks ER-to-golgi trafficking and inhibits lupus pathology","volume":"66","author":"Prabakaran","year":"2021","journal-title":"eBioMedicine"},{"key":"10.1016\/j.ijrobp.2023.05.032_bib0061","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.621550","article-title":"Combination of interleukin-15 with a STING agonist, ADU-S100 analog: A potential immunotherapy for prostate cancer","volume":"11","author":"Esteves","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.ijrobp.2023.05.032_bib0062","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1089\/jir.2017.0127","article-title":"Development of a validated interferon score using nanostring technology","volume":"38","author":"Kim","year":"2018","journal-title":"J Interferon Cytokine Res"},{"key":"10.1016\/j.ijrobp.2023.05.032_bib0063","doi-asserted-by":"crossref","first-page":"15618","DOI":"10.1038\/ncomms15618","article-title":"DNA exonuclease Trex1 regulates radiotherapy-induced tumour immunogenicity","volume":"8","author":"Vanpouille-Box","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.ijrobp.2023.05.032_bib0064","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.jacbts.2018.01.014","article-title":"Radiation-induced endothelial vascular injury","volume":"3","author":"Venkatesulu","year":"2018","journal-title":"JACC Basic Transl Sci"},{"key":"10.1016\/j.ijrobp.2023.05.032_bib0065","doi-asserted-by":"crossref","first-page":"224","DOI":"10.2307\/3577549","article-title":"Radiosensitivity of CD4 or CD8 positive human T-lymphocytes by an in vitro colony formation assay","volume":"123","author":"Nakamura","year":"1990","journal-title":"Radiat Res"},{"key":"10.1016\/j.ijrobp.2023.05.032_bib0066","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.critrevonc.2018.01.003","article-title":"A systematic review of the influence of radiation-induced lymphopenia on survival outcomes in solid tumors","volume":"123","author":"Venkatesulu","year":"2018","journal-title":"Crit Rev Oncol Hematol"},{"issue":"15 Suppl","key":"10.1016\/j.ijrobp.2023.05.032_bib0067","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1200\/jco.2015.33.15_suppl.1069","article-title":"Lymphopenia after adjuvant radiotherapy (RT) to predict poor survival in triple-negative breast cancer (TNBC)","volume":"33","author":"Afghahi","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2023.05.032_bib0068","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1007\/s13277-015-3888-y","article-title":"Radiation-related lymphopenia as a new prognostic factor in limited-stage small cell lung cancer","volume":"37","author":"Cho","year":"2016","journal-title":"Tumour Biol"},{"key":"10.1016\/j.ijrobp.2023.05.032_bib0069","doi-asserted-by":"crossref","first-page":"E478","DOI":"10.1016\/j.ijrobp.2016.06.1831","article-title":"Lymphocyte depletion by radiation therapy alone is associated with poor survival in non-small cell lung cancer","volume":"96","author":"Joo","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2023.05.032_bib0070","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1002\/hed.23535","article-title":"Association between severe treatment-related lymphopenia and progression-free survival in patients with newly diagnosed squamous cell head and neck cancer","volume":"36","author":"Campian","year":"2014","journal-title":"Head Neck"},{"key":"10.1016\/j.ijrobp.2023.05.032_bib0071","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/j.ijrobp.2014.04.025","article-title":"Lymphopenia association with gross tumor volume and lung V5 and its effects on non-small cell lung cancer patient outcomes","volume":"89","author":"Tang","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2023.05.032_bib0072","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.ijrobp.2015.11.026","article-title":"Lymphocyte-sparing effect of stereotactic body radiation therapy in patients with unresectable pancreatic cancer","volume":"94","author":"Wild","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"15 Suppl","key":"10.1016\/j.ijrobp.2023.05.032_bib0073","doi-asserted-by":"crossref","first-page":"e18513","DOI":"10.1200\/jco.2015.33.15_suppl.e18513","article-title":"Lymphopenia as a predictor of survival in chemoradiation (CRT)-treated stage III non-small cell lung cancer (NSCLC)","volume":"33","author":"Yellu","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2023.05.032_bib0074","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1080\/0284186X.2017.1346385","article-title":"Hunting for abscopal and bystander effects: Clinical exploitation of non-targeted effects induced by partial high-single-dose irradiation of the hypoxic tumour segment in oligometastatic patients","volume":"56","author":"Tubin","year":"2017","journal-title":"Acta Oncol"},{"key":"10.1016\/j.ijrobp.2023.05.032_bib0075","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/s13014-019-1410-1","volume":"14","author":"Tubin","year":"2019","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2023.05.032_bib0076","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s13014-019-1227-y","article-title":"Novel stereotactic body radiation therapy (SBRT)-based partial tumor irradiation targeting hypoxic segment of bulky tumors (SBRT-PATHY): Improvement of the radiotherapy outcome by exploiting the bystander and abscopal effects","volume":"14","author":"Tubin","year":"2019","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2023.05.032_bib0077","unstructured":"Tubin S. Clinical exploration of the non-targeted effects of stereotactic radiotherapy in patients with unresectable bulky tumors treated by partial high-dose irradiation of hypoxic tumor segment: Phase I proof of principle trial. Available at: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04168320. Accessed December 29, 2021."}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301623005217?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301623005217?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T10:09:48Z","timestamp":1759745388000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301623005217"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":77,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["S0360301623005217"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2023.05.032","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Activation of STING in Response to Partial-Tumor Radiation Exposure","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2023.05.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}